EYAL RUBIN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protalix BioTherapeutics, Inc.

Filing Date Source Excerpt
2019-10-15 July — Appointment of Eyal Rubin as our new Sr. Vice President & Chief Financial Officer
2021-09-30 Eyal Rubin Sr. Vice President and Chief Financial Officer and Corporate Secretary

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09